Who
Jeff Cislini
SVP & General Counsel
Company insider
Files Form 4 as: SVP & General Counsel, Revolution Medicines.
In numbers
- Trades disclosed
- 81
- Buys
- 0
- Sells
- 35
- Bought
- $0
- Sold
- $30.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Jun 2023
- Last trade
- 25 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Sep 2026filed 29 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $159K765 at $207.32 | filing |
| 25 Sep 2026filed 29 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $159K765 at $207.32 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $10K52 at $195.01 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $660K3,314 at $199.30 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $10K52 at $195.01 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $660K3,314 at $199.30 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code M | $551K29,680 at $18.56 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —26,600 at $0.00 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code M | $575K26,600 at $21.61 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $705K3,400 at $207.24 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —29,680 at $0.00 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —26,600 at $0.00 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $3.6M17,323 at $208.37 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $5.4M25,817 at $209.25 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $534K2,540 at $210.26 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $951K4,500 at $211.34 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $703K3,314 at $212.06 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —29,680 at $0.00 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code M | $551K29,680 at $18.56 | filing |
| 21 Aug 2026filed 25 Aug 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code M | $575K26,600 at $21.61 | filing |
News
Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026RVMD · manilatimes.net · 23 Oct 2026Contrasting Revolution Medicines (NASDAQ:RVMD) and Agios Pharmaceuticals (NASDAQ:AGIO)RVMD · themarketsdaily.com · 22 Oct 2026Revolution Medicines (NASDAQ:RVMDW) Stock Jumps 4.2% – Time to Buy?RVMD · tickerreport.com · 21 Oct 2026
0 headlines in the last 90 days name Jeff Cislini; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.